Harvard Bioscience (FRA:HBI) Total Stockholders Equity : €63.31 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Harvard Bioscience Total Stockholders Equity?

Harvard Bioscience's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €63.31 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Harvard Bioscience's Book Value per Share for the quarter that ended in Mar. 2024 was €1.46. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Harvard Bioscience's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.60.

Harvard Bioscience Total Stockholders Equity Historical Data

The historical data trend for Harvard Bioscience's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Bioscience Total Stockholders Equity Chart

Harvard Bioscience Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

73.53

63.03

73.81

68.18

67.01

Harvard Bioscience Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															69.43	69.58	69.61	67.01	63.31

Harvard Bioscience (FRA:HBI) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Harvard Bioscience's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(63.307	-	0)	/	43.4212
	=	1.46

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Harvard Bioscience's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.524	+	33.531)	/	63.307
	=	0.60

Harvard Bioscience Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Harvard Bioscience's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Harvard Bioscience (FRA:HBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Harvard Bioscience Inc (FRA:HBI) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

HBIO:USA HBI:Germany

Address

84 October Hill Road, Holliston, MA, USA, 01746

Website

https://www.harvardbioscience.com

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.